1034152-95-8Relevant articles and documents
Discovery of MK-7725, a potent, selective bombesin receptor subtype-3 agonist for the treatment of obesity
Chobanian, Harry R.,Guo, Yan,Liu, Ping,Chioda, Marc,Lanza, Thomas J.,Chang, Linda,Kelly, Theresa M.,Kan, Yanqing,Palyha, Oksana,Guan, Xiao-Ming,Marsh, Donald J.,Metzger, Joseph M.,Gorski, Judith N.,Raustad, Kate,Wang, Sheng-Ping,Strack, Alison M.,Miller, Randy,Pang, Jianmei,Madeira, Maria,Lyons, Kathy,Dragovic, Jasminka,Reitman, Marc L.,Nargund, Ravi P.,Lin, Linus S.
supporting information; experimental part, p. 252 - 256 (2012/07/13)
Extensive structure-activity relationship studies of a series derived from atropisomer 1, a previously described chiral benzodiazepine sulfonamide series, led to a potent, brain penetrant and selective compound with excellent preclinical pharmacokinetic a